GLYCOSELECT

glycoselect-logo

GlycoSeLect specialises in the development and production of Recombinant Prokaryotic Lectins (RPLs), enhanced tools for the analysis and selective purification of glycosylated biomolecules. RPLs have a broad spectrum of applications across the life sciences in: - Basic R&D โ€“ Glycobiology & Glycoproteomics. - Biomarker Discover & Biomedical Diagnostics. - The Biopharmaceutical Industry. - Vaccines - Cosmetics GlycoSeLect's Recombinant Prokaryotic Lectins (RPLs) present significant adv... antages over existing commercially available lectins products including: - Simplified, rapid & cost effective production through recombinant expression in Escherichia coli. - High purity & consistent performance. - Genetically enhanced glycan binding properties (specificity & affinity). - Scalable production facilitating utilization for large scale applications.

#SimilarOrganizations #People #Financial #Website #More

GLYCOSELECT

Social Links:

Industry:
Biotechnology Life Science Medical

Founded:
2013-10-01

Address:
Dublin, Dublin, Ireland

Country:
Ireland

Website Url:
http://www.glycoselect.com

Total Employee:
1+

Status:
Active

Contact:
+353877902652

Email Addresses:
[email protected]

Total Funding:
450 K EUR

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

spark-therapeutics-logo

Spark Therapeutics

Spark Therapeutics is focused on the development of gene therapy.

Current Employees Featured

robert-dunne_image

Robert Dunne
Robert Dunne Chief Executive Officer @ GlycoSeLect
Chief Executive Officer
2013-01-01

not_available_image

Roisin Thompson
Roisin Thompson Chief Technical Officer @ GlycoSeLect
Chief Technical Officer
2013-01-01

prathima-s-acharya_image

Prathima S. Acharya
Prathima S. Acharya Scientific Board Advisor @ GlycoSeLect
Scientific Board Advisor
2016-10-01

Founder


paul-clarke_image

Paul Clarke

Investors List

kbi-biopharma_image

KBI Biopharma

KBI Biopharma investment in Seed Round - GlycoSeLect

enterprise-ireland_image

Enterprise Ireland

Enterprise Ireland investment in Seed Round - GlycoSeLect

Official Site Inspections

http://www.glycoselect.com

  • Host name: aqua.webhostingireland.ie
  • IP address: 91.210.232.215
  • Location: Dublin Ireland
  • Latitude: 53.3338
  • Longitude: -6.2488
  • Timezone: Europe/Dublin
  • Postal: D02

Loading ...

More informations about "GlycoSeLect"

GlycoSeLect - Crunchbase Company Profile & Funding

Organization. GlycoSeLect . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... GlycoSeLect specialises in the โ€ฆSee details»

About Us - GlycoSeLect

GlycoSeLect News Stories. Chemistsโ€™ technique reveals whether antibodies neutralize SARS-CoV-2. Bio-Layer Interferometry with Recombinant Prokaryotic Lectins. Recombinant โ€ฆSee details»

GlycoSeLect Ltd - LinkedIn

GlycoSeLectโ€™s family of RPLs products are associated with market-leading properties, including high affinity for glycan targets, high sensitivity of detection, high stability and robustness in ...See details»

Management - GlycoSeLect

GlycoSeLect News Stories. Chemistsโ€™ technique reveals whether antibodies neutralize SARS-CoV-2. GlycoSeLect signs distribution agreement with MJS BioLynx Inc. GlycoSeLect enters strategic agreement with DBA Italia. New โ€ฆSee details»

GlycoSeLect 2025 Company Profile: Valuation, Funding ... - PitchBook

GlycoSeLect was founded in 2013. Where is GlycoSeLect headquartered? GlycoSeLect is headquartered in Dublin, Ireland. What is the size of GlycoSeLect? GlycoSeLect has 4 total โ€ฆSee details»

GlycoSeLect - Contacts, Employees, Board Members, Advisors

GlycoSeLect specializes in the development of technology to separate glycoproteins for biopharmaceutical product analysis & manufacture. ... Experience the new Crunchbase, โ€ฆSee details»

GlycoSeLect Company Profile - Office Locations, Competitors

GlycoSeLect has 5 employees at their 1 location and $528.82 k in total funding,. See insights on GlycoSeLect including office locations, competitors, revenue, financials, executives, โ€ฆSee details»

GlycoSeLect - Funding, Financials, Valuation & Investors

How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Oct 24, 2017: Seed Round - โ€ฆSee details»

GlycoSeLect - VentureRadar

Similar Companies: Coppetec Foundation Unknown n/a The Cell Culture Engineering Lab of the Federal University of Rio de Janeiro, suported by Coppetec Foundation, has over 10 years of โ€ฆSee details»

GlycoSelect Ltd. - Drug pipelines, Patents, Clinical trials - Synapse

Explore GlycoSelect Ltd. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»

Glycoselect Limited - Advanced Therapeutics Web Portal Ireland

GlycoSeLect Limited is an Irish company founded in 2013. Our technology is built on over 10 years of research in Dublin City University (DCU). GlycoSeLect specialises in the development โ€ฆSee details»

Glycoselect: Recombinant Prokaryotic Lectins - Sobekbio

GlycoSeLect Ltd specializes in the development and production of Recombinant Prokaryotic Lectins (RPLs). RPLs are glycoselective bioaffinity compounds, they recognize and bind to โ€ฆSee details»

JSR Life Sciences and GlycoSeLect Enter Licensing and Joint โ€ฆ

Sunnyvale, CA, โ€ October 31, 2019 โ€ JSR Life Sciences announced today that it has signed a technology licensing and joint development agreement with Dublin, Ireland-based โ€ฆSee details»

GlycoSeLect Announces Investment & Development Partnership โ€ฆ

GlycoSeLect Ltd is an early-stage biotechnology company developing proprietary next-generation, highly specific and cost-efficient tools for the analysis, characterization and purification of โ€ฆSee details»

Meet the Team - GlycoSeLect

GlycoSeLect News Stories. Chemistsโ€™ technique reveals whether antibodies neutralize SARS-CoV-2. GlycoSeLect signs distribution agreement with MJS BioLynx Inc. GlycoSeLect enters โ€ฆSee details»

Targeting key glycoproteins: Glucose oxidase - GlycoSeLect

Aug 23, 2021 Using GlycoSeLect RPL products to enable the isolation and identification of key protein glucose oxidase in a variety of applications. By Simarjot Kaur, Scientist at โ€ฆSee details»

Glycoselect | labclinics.com

Biotechnology, genetics and sequencing. CRISPR Genetic Screening; mRNA; Methylation Assays; Cytogenetic Analysis; BioanalysisSee details»

CPI Supports GlycoSeLect to Develop High Throughput Glycan

The collaboration between CPI, GlycoSeLect UK Ltd, ForteBio-Molecular Devices and Allergan Biologics Ltd addressed the need for new analytical approaches to satisfy the growing โ€ฆSee details»

Applications - GlycoSeLect

GlycoSeLect News Stories. Chemistsโ€™ technique reveals whether antibodies neutralize SARS-CoV-2. Bio-Layer Interferometry with Recombinant Prokaryotic Lectins. Recombinant โ€ฆSee details»

linkstock.net © 2022. All rights reserved